New CDC Acting Director Faces Challenges Amid Controversy and Uncertainty
TL;DR Summary
Jim O'Neill, a biotech investor and former HHS deputy, has been appointed as the acting CDC director amid controversy due to his lack of medical background and history of supporting unproven COVID treatments and political rhetoric, raising concerns about his influence on public health policies.
- What to know about Jim O'Neill, new acting CDC director Axios
- Will the C.D.C. Survive? The New York Times
- CDC official who blasted Trump’s ‘weak science’ led politicized Biden-era monkeypox response Fox News
- It's been a week of chaos at the CDC. Here are 5 things to know NPR
- The new head of the CDC has no training in medicine and once helped Peter Thiel develop man-made islands floating outside U.S. territory Fortune
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
89%
428 → 45 words
Want the full story? Read the original article
Read on Axios